204 related articles for article (PubMed ID: 1667398)
1. Calcium channels and calcium channel blockers.
Seth SD; Seth S
Indian J Physiol Pharmacol; 1991 Oct; 35(4):217-31. PubMed ID: 1667398
[No Abstract] [Full Text] [Related]
2. Current and potential indications for Ca2+ antagonists.
Scriabine A
Ration Drug Ther; 1987 Nov; 21(11):1-7. PubMed ID: 3328218
[No Abstract] [Full Text] [Related]
3. [The central effect of calcium antagonists].
Siembab D; Janicki PK; Rewerski W
Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1676-8. PubMed ID: 2855863
[No Abstract] [Full Text] [Related]
4. Calcium channel blockers in the treatment of disease.
Elmslie KS
J Neurosci Res; 2004 Mar; 75(6):733-41. PubMed ID: 14994334
[TBL] [Abstract][Full Text] [Related]
5. [Calcium antagonists. Pharmacology and clinical pharmacology].
Grobecker H
Med Monatsschr Pharm; 1994 May; 17(5):130-9. PubMed ID: 8022361
[No Abstract] [Full Text] [Related]
6. [Advance in calcium channel blockers relaxing corpus cavernosum smooth muscle].
Xiao HJ; Liu JH
Zhonghua Nan Ke Xue; 2003 Feb; 9(1):55-7. PubMed ID: 12680335
[TBL] [Abstract][Full Text] [Related]
7. Calcium-antagonist drugs.
Abernethy DR; Schwartz JB
N Engl J Med; 1999 Nov; 341(19):1447-57. PubMed ID: 10547409
[No Abstract] [Full Text] [Related]
8. Ca2+ channel subtypes and pharmacology in the kidney.
Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
[TBL] [Abstract][Full Text] [Related]
9. [Perspective of calcium antagonist].
Kim-Mitsuyama S
Clin Calcium; 2005 Jan; 15(1):81-6. PubMed ID: 15632476
[TBL] [Abstract][Full Text] [Related]
10. Calcium channel blockers.
Hurwitz CU
CRNA; 1996 Feb; 7(1):29-32. PubMed ID: 8680353
[TBL] [Abstract][Full Text] [Related]
11. Linking calcium-channel isoforms to potential therapies.
Belardetti F; Zamponi GW
Curr Opin Investig Drugs; 2008 Jul; 9(7):707-15. PubMed ID: 18600576
[TBL] [Abstract][Full Text] [Related]
12. [Effects of calcium channel blockers in atherosclerosis and cardiovascular event and oxidative vascular damage].
Fujino T; Sumitomo K; Hasebe N; Kikuchi K
Clin Calcium; 2004 Jan; 14(1):119-27. PubMed ID: 15576967
[TBL] [Abstract][Full Text] [Related]
13. Calcium channel blockers for cardiovascular disorders.
Karlsberg RP
Arch Intern Med; 1982 Mar; 142(3):452-5. PubMed ID: 6279045
[No Abstract] [Full Text] [Related]
14. [Amlodipine and the mechanisms of vascular hypertrophy].
Marche P
Drugs; 2000; 59 Spec No 2():1-7. PubMed ID: 11002853
[TBL] [Abstract][Full Text] [Related]
15. [Calcium channel as molecular target of drug action].
Taglialatela M; Annunziato L; Marino A
Clin Ter; 1989 Dec; 131(5):299-305. PubMed ID: 2558001
[TBL] [Abstract][Full Text] [Related]
16. [Calcium channel blocking agents: evaluation and perspectives].
Lebrun P
Rev Med Brux; 1988 Jun; 9(5):280-9. PubMed ID: 2457930
[No Abstract] [Full Text] [Related]
17. [Pharmacological basis of Ca2+ channels and Ca2+ channel antagonists].
Adachi-Akahane S
Clin Calcium; 2005 Oct; 15(10):1589-97. PubMed ID: 16199903
[TBL] [Abstract][Full Text] [Related]
18. [Pleiotropic effects of new generation calcium channel blockers on cardiovascular protections].
Ogimoto A; Higaki J
Clin Calcium; 2013 Apr; 23(4):569-74. PubMed ID: 23545747
[TBL] [Abstract][Full Text] [Related]
19. Neuroanatomic and neurophysiologic changes in the aging brain.
Kelly KM
Geriatrics; 2005 May; Suppl():4-6, 19. PubMed ID: 16025881
[No Abstract] [Full Text] [Related]
20. [Calcium channels, calcium pumps and calcium antagonists].
Schaub MC
Schweiz Rundsch Med Prax; 1987 Feb; 76(7):165-70. PubMed ID: 2437636
[No Abstract] [Full Text] [Related]
[Next] [New Search]
